Proteins are frequently modified to improve their affinity for ligands, a crucial aspect for therapeutic purposes. Traditionally, methods like phage or yeast display libraries have been used to evolve antibodies and T cell receptors (TCRs) for enhanced affinity. However, these methods have limitations in assessing the entire protein-protein interface rapidly. Combining directed evolution with deep sequencing has enabled the creation of sequence fitness landscapes, providing a comprehensive view of the impact of amino acid substitutions across the interface. In a study focusing on a TCR-peptide-MHC interaction, deep mutational scans guided mutational strategies leading to stable TCRs with over 200-fold affinity increases. Computational models effectively predicted affinity changes for mutations near the interface, showcasing the synergy between computational modeling and experimental approaches for engineering high-affinity TCRs.
T cells play a vital role in immune responses, recognizing antigens presented by the major histocompatibility complex (MHC). While antibodies naturally undergo affinity maturation through somatic mutations, TCRs typically exhibit low affinities for their targets. However, through in vitro methods involving mutant TCR libraries and antigen selection, TCR affinity enhancements comparable to antibodies can be achieved. Directed evolution approaches, including yeast and mammalian display, have successfully improved the affinity of various protein-protein interactions, including TCR-pMHC interactions.
Recent advancements in deep sequencing of single-codon libraries have enabled the creation of sequence fitness landscapes, offering insights into protein interactions on a residue-by-residue basis. By analyzing the fitness landscape of a cancer antigen-specific TCR, mutations that significantly increased affinity were identified. Further exploration involved individual and combined mutations, culminating in TCR variants with remarkable affinity gains. Computational modeling provided structural interpretations and predicted the impacts of mutations, aiding in understanding the basis of affinity improvements.
Experimental evaluation of mutations identified through deep mutational scans revealed that certain mutations, when combined, led to substantial affinity enhancements. Combinatorial libraries at key residues demonstrated the potential for identifying synergistic mutations that individually may not have shown significant improvements. Comparing experimental results with computational predictions highlighted the importance of considering protein stability in addition to affinity in engineering high-affinity TCRs. Mutations that showed enhanced affinity often correlated with reduced exposed hydrophobic surface area, emphasizing the impact of stability on binding interactions.
Predictive computational models successfully recapitulated the relative binding energies of mutant TCRs, aiding in rationalizing how mutations influenced binding. For instance, mutations that introduced new interactions or improved packing within the binding interface were associated with significant affinity gains. Interestingly, mutations distal to the interface played crucial roles in enhancing affinity, underscoring the importance of comprehensive mutational analyses in protein engineering.
In conclusion, the integration of deep mutational scanning, experimental validation, and computational modeling offers a potent strategy for engineering high-affinity TCRs. By leveraging sequence fitness landscapes and structural insights, researchers can design targeted mutations to improve protein-protein interactions effectively. This multidisciplinary approach not only enhances our understanding of protein engineering but also paves the way for developing novel therapeutics with optimized binding properties.
Key Takeaways:
1. Deep mutational scans coupled with computational modeling and experimental validation offer a comprehensive approach to engineer high-affinity TCRs.
2. Comprehensive mutational analyses, considering both affinity and stability, are crucial for designing effective protein engineering strategies.
3. Synergistic mutations identified through combinatorial libraries can lead to significant affinity enhancements in TCRs.
4. Protein engineering techniques combining experimental and computational methods hold promise for developing next-generation therapeutics with enhanced binding properties.
Tags: inclusion bodies, yeast display, yeast, protein engineering, directed evolution, immunotherapy, mammalian display, quality control
Read more on pmc.ncbi.nlm.nih.gov